Sudafed, Tylenol, DayQuil, NyQuil and Store Brand Cold and Flu Medicines
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
DayQuil Super C
Case Name (Date)
Kampmann et al. v. The Procter & Gamble Co.
23-cv-1021, C.D. Ill.
(Jan. 2023)
Product/Service
DayQuil Super C
Allegations
Misleadingly marketing products as if they alleviate cold and flu symptoms when fine print on the side of the product packaging discloses that the products are “not intended to treat colds or flu”
Status
Class-Action Tracker
DayQuil Cough Medicine
Allegations: Falsely marketing medicine as “non-drowsy” when an ingredient causes drowsiness
DayQuil Medicines with DXM
Allegations: Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
The Latest
9 Earth-Friendly Claims to Watch Out for This Earth Day
Green marketing claims you should think twice about.
Swiffer Swept up in Broom-Bashing Claims
Self-regulatory body calls supporting evidence behind superiority claims “materially flawed.”
Five Companies that Fail the Name Game
What’s in a name? Sometimes not what you expect.
Does the Executive Suite Match the Empowerment Message in the Ad?
Here’s what the Super Bowl’s #likeagirl ad really means.
The Problem with Flushing Flushable Wipes
They’re advertised as “flushable” but wastewater officials and consumers say that claim falls short.